Page 61
O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n
Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018
Biomedical Research
|
ISSN: 0976-1683
|
Volume 29
2
nd
WORLD OBESITY CONGRESS
2
nd
WORLD VACCINES AND IMMUNOLOGY CONGRESS
&
&
DIABETES AND ENDOCRINOLOGY
International Conference on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-014
EFFECT OF
NIGELLA SATIVA
SEEDS ON THE GLYCEMIC CONTROL OF
PATIENTS WITH TYPE1 DIABETES MELLITUS IN NILE RIVER STATE
Omer A Musa
and
Malak E Ahmed
The National Ribat University, Sudan
N
igella sativa
(NS) is widely used medicinal plant throughout the world. Seeds and oil have a long history of usage in various
aspects of medicines and food. It has is used to treat a wide range of diseases including diabetes mellitus (DM). DM is a
chronic incurable disease with high mortality and morbidity and increasing prevalence. The aim of this study was to investigate
hypoglycemic effect (NS) in type 1 diabetic patients. Nine patients with type I diabetes were included in the study. They were giv-
en NS (2 gm per day) beside their regular treatment (insulin) for 30 days. At the end of the study fasting blood glucose (FBG) was
checked and data was analyzed using t-test and paired t-test in statistical package for the social sciences (SPSS) 22 software.
The mean levels of FBS before and one month after the intervention were 227±65, 128±57.6 respectively. There was significant
reduction in FBS before and after treatment (P=0.003). Results showed a significant improvement in FBG in type 1 diabetic pa-
tient used NS for 30 days. More studies are recommended in the future to determine the optimal dose, duration and frequency
of NS as an antidiabetic drug as well as to study effect of NS in prevention of diabetic complication.
omusa56@yahoo.co.uk